• Mesoblast shares: Q4 earnings top projections

    a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.

    The Mesoblast Ltd (ASX: MSB) share price is in focus today after the company reported fourth-quarter net revenue of US$36 million, boosting full-year revenue to US$115 million for the period ended 30 June 2026.

    What did Mesoblast report?

    • Fourth quarter net revenue: US$36 million
    • Full-year net revenue: US$115 million
    • Ryoncil® uptake exceeded initial projections
    • Strong capital position and funding for operations

    What else do investors need to know?

    Ryoncil® is the first mesenchymal stromal cell (MSC) product approved by the US FDA for any indication and remains the only FDA-approved option for children under 12 with steroid-refractory acute graft-versus-host disease (SR-aGvHD). This achievement has positioned Mesoblast as a leading developer of allogeneic cellular medicines targeting severe inflammatory diseases.

    The company’s manufacturing capabilities continue to deliver industrial-scale, off-the-shelf cellular medicines. Mesoblast also has an extensive intellectual property portfolio, with patents that provide commercial protection through to at least 2044 in key markets.

    What’s next for Mesoblast?

    Looking ahead, Mesoblast expects continued revenue growth, supported by momentum across major US paediatric centres. The company’s robust capital base and new five-year facility are intended to support further strategic initiatives, including label extensions and new blockbuster product launches.

    Mesoblast is advancing its Ryoncil® therapy for additional inflammatory diseases, such as SR-aGvHD in adults and biologic-resistant inflammatory bowel disease, while its rexlemestrocel-L platform targets heart failure and chronic low back pain.

    Mesoblast share price snapshot

    Over the past 12 months, Mesoblast shares have risen 27%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 2% over the same period.

    View Original Announcement

    The post Mesoblast shares: Q4 earnings top projections appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Mesoblast right now?

    Before you buy Mesoblast shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Mesoblast wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Australia may sign a nuclear deal with India this week. What does that mean for Boss Energy shares?

    A worker with a clipboard stands in front of a nuclear energy facility.

    Boss Energy Ltd (ASX: BOE) shares have had a difficult year.

    After a savage 43.8% single-day fall in July 2025 following a production guidance cut at its Honeymoon uranium mine in South Australia, the stock has struggled to recover, sitting approximately 20% lower year to date.

    This week, however, a significant catalyst has emerged that the market is watching closely.

    There are reports that the Australian Government could sign an agreement with India this week that delivers on a nuclear co-operation plan between the two countries.

    If confirmed, the agreement would open the door for Australia to export uranium directly to India. One of the world’s fastest-growing nuclear markets.

    Why India could be a big buyer of uranium

    India’s nuclear ambition is not speculative.

    RBC Capital Markets noted in a recent report that India has committed to growing its nuclear capacity tenfold by 2047. This is one of the most significant long-term demand commitments any country has made to nuclear energy.

    India currently generates approximately 3% of its electricity from nuclear power, compared to 70% in France and 19% in the United States.

    Reaching its 2047 target would require an extraordinary buildout of reactor capacity over the next two decades and a corresponding, sustained surge in uranium demand.

    Australia holds more than one-third of the world’s known uranium reserves, making it the largest reserve holder on the planet.

    However, Australia has historically been unable to supply uranium directly to India because the two countries lacked the bilateral safeguards agreement required under Australia’s strict uranium export policy.

    That is what the agreement being reported this week would change.

    What it means for Boss Energy shares

    Boss Energy surged 12.2% in a single session on 3 July after meeting its revised FY26 production guidance of 1.41 million pounds of uranium at its Honeymoon project.

    That bounce confirmed the market is still willing to respond positively to strong operational news.

    A confirmed nuclear deal with India would be a far more significant catalyst than a production update. This is because it would open a new, large export market for Australian uranium producers at a time when global uranium demand is already strengthening.

    Shaw and Partners carries a buy rating on Boss Energy with a price target of $3.15, implying significant upside. These ratings were based on an upgraded uranium price forecast that sees the fuel reaching US$175 per pound in 2027.

    The broker described the uranium market backdrop as one where:

    Energy security, decarbonisation and AI-driven power demand are converging. Nuclear is no longer a fringe solution. It is becoming central to energy policy.

    The risks investors need to understand

    Boss Energy is not a risk-free investment, and the India deal has not yet been confirmed.

    The Honeymoon project has had a difficult operational history, with production guidance cut twice in FY26 and a new feasibility study still in progress.

    A new feasibility study is targeting completion in Q3 calendar year 2026, which will determine the long-term production outlook for the mine.

    Until that study is complete, there is uncertainty about what Honeymoon can produce at scale, and at what cost.

    Furthermore, uranium spot prices remain volatile, and the India deal, even if signed, would take time to translate into actual contracts and physical uranium deliveries.

    Foolish Takeaway for Boss Energy shares

    Boss Energy shares are down in 2026 on the back of a difficult operational year.

    A nuclear co-operation agreement with India, if signed this week, would be the most significant demand-side catalyst the Australian uranium sector has received in years.

    Whether that translates into a sustained recovery for Boss Energy depends partly on the Honeymoon feasibility study delivering a credible long-term production case.

    Investors should watch both developments closely in the weeks ahead.

    The post Australia may sign a nuclear deal with India this week. What does that mean for Boss Energy shares? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Boss Energy Ltd right now?

    Before you buy Boss Energy Ltd shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Boss Energy Ltd wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Ingenia Communities Group shares paused pending announcement

    an attractive woman gives a time out signal with her hands, holding them in a T shape, indicating a trading halt.

    The Ingenia Communities Group (ASX: INA) share price is in focus today after the company’s securities were temporarily paused pending a further announcement.

    What did Ingenia Communities Group report?

    • Trading in Ingenia securities has been paused by the ASX as of 10 July 2026
    • No earnings or financial metrics were released in this announcement
    • Pause is pending a further announcement from Ingenia Communities Group
    • Investors are awaiting more information to clarify the reason for the trading halt

    What else do investors need to know?

    Investors should note that a trading pause does not always signal negative news—it can occur for a range of reasons, such as pending news about transactions, capital raisings, or regulatory matters. It’s a standard ASX procedure to ensure orderly trading and fair disclosure for all shareholders.

    Ingenia Communities Group has stated a further announcement will follow, at which point the company is expected to provide more detail behind the trading halt.

    What’s next for Ingenia Communities Group?

    With securities suspended, all eyes will be on Ingenia’s next update. Whether it’s about a material transaction, major development, or other sensitive information, investors should keep an eye on Ingenia’s ASX releases for developments.

    Until the next announcement is released, Ingenia’s share price will remain paused on the ASX. The company’s next statement will likely clarify the situation for shareholders.

    Ingenia Communities Group share price snapshot

    Over the past 12 months, Ingenia shares have declined 16%, trailing the S&P/ASX 200 Index (ASSX: XJO), which has risen 3% over the same period

    View Original Announcement

    The post Ingenia Communities Group shares paused pending announcement appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Ingenia Communities Group right now?

    Before you buy Ingenia Communities Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Ingenia Communities Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Stock market is almost back to where it was before all this coronavirus crap happened! Makes no FUCKING SENSE! How long can the government keep their Brrrrrrrrr infinite fucking money solution going for!?

  • 3 ASX 200 shares to watch this week

  • Why Fisher & Paykel Healthcare, Graincorp, Polynovo, & SEEK are dropping lower

  • ASX tourism shares on watch as government flags easing of coronavirus restrictions